Menu
Search
Home > Courses > Fighting a Moving Target: SARS-CoV-2 Evolution and Viral Escape in COVID-19

Fighting a Moving Target: SARS-CoV-2 Evolution and Viral Escape in COVID-19

Fighting a Moving Target: SARS-CoV-2 Evolution and Viral Escape in COVID-19
Play
Sorry, this learning module is not available for mobile devices.
Original Release Date: 2/17/2021
Termination Date: 02/16/2024
Review Date: 5/28/2021
Learning Objectives / Desired Outcomes
At the completion of this educational activity, participants will:
  1. Contrast viral evolution in SARS-CoV-2 with other viruses.
  2. Compare SARS-CoV-2 persistence versus reinfection.
  3. Define novel strains of SARS-CoV-2 and impact on the epidemic.
Presenter
  • Jonathan Z. Li, MD, MMSc
    Assistant Professor of Medicine, Director of the Harvard/Brigham Virology Specialty Laboratory, Director of the Harvard University Center for AIDS Research Clinical Core
    Brigham and Women’s Hospital, Harvard Medical School, Cambridge, MA
Presenter Bio
Jonathan Li, MD, MMSc
Jonathan Z. Li, MD, MMSc is an infectious disease physician-scientist at the Brigham and Women’s Hospital and Harvard Medical School. He leads an active clinical and translational laboratory research program focused on viral detection, reservoirs and resistance, especially within the fields of HIV and COVID-19. Dr. Li is the Director of the Harvard University Virology Specialty Laboratory, the Director of the Harvard University Center for AIDS Research Clinical Core, and a member of the AIDS Clinical Trials Group (ACTG) Executive Committee. He is the protocol virologist for A5401/ACTIV-2 Adaptive Platform Treatment Trial for Outpatients with COVID-19, the protocol Chair of the ACTG A5308 study of ART treatment for HIV-1 controllers, and the Chair of the A5345 study of biomarkers of HIV rebound. Dr. Li also serves as the Deputy Editor for the Infectious Disease Society of America (IDSA) journal Open Forum Infectious Diseases and on the Editorial Advisory Board for the Journal of Infectious Diseases.
Continuing Education Credit

This CME activity was approved for AMA PRA Category 1 Credit on February 17, 2021 and will terminate February 16, 2023.

The target audience is all Physicians, Nurse Practitioners, and Physician Assistants caring for people at risk for, or infected with HIV and/or viral hepatitis.


This online video and post-activity evaluation are one hour in length.

  • After you complete the video portion of this educational activity there will be a post-activity evaluation and quiz.
  • You must achieve at least 70% correct to receive your CME certificate.
  • If successful, you will be provided instructions to print your CME certificate at the completion of this activity.

 Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Medical Society of the State of New York (MSSNY) and the Physicians’ Research Network (PRN). MSSNY is accredited by the ACCME to provide continuing medical education for physicians.


The Medical Society of the State of New York designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit. Physicians should claim only the credit commensurate with extent of their participation in the activity.

Disclosure Statement 

Policies and standards of MSSNY require that speakers and planners for CME activities disclose any relevant financial relationships they may have with commercial interests whose products, devices or services may be discussed in the content of a CME activity.  

  • Dr. James Braun (Planner/Course Director) has no relevant financial relationships to disclose.
  • Dr. William M. Valenti (Moderator) has no relevant financial relationships to disclose
  • Dr. Jonathan Z. Li (Presenter) has no relevant financial relationships to disclose. Dr. Li will support his presentation and clinical recommendations with the best available evidence from the medical literature, and will submit his slides in advance for adequate peer review.  

This meeting of the Physicians’ Research Network (PRN) and enduring material were funded in part by educational grants from: Gilead Sciences, Janssen Therapeutics (a division of Janssen Products, LP), Merck & Co., and ViiV Healthcare.

Details: 

  • This online video and post-activity evaluation are one hour in length. 
  • After you complete the video portion of this educational activity there will be a post-activity evaluation and quiz. 
  • You must achieve at least 70% correct to receive your CME certificate. 
  • If successful, you will be provided instructions to print your CME certificate at the completion of this activity.
PRN Learning Modules